NEXT
Search Results

0 results for 'Novo Nordisk'

You can use to get even better search results
June 04, 2024 | Legaltech News

LegalZoom Sued for Alleged Unauthorized Practice of Law in NJ Class Action

LegalZoom allegedly engages in the unauthorized practice of law because it does not fit the statutory definition of a professional service corporation and because its owners include nonlawyers, according to the complaint, which was first surfaced by Law.com Radar.
5 minute read
June 04, 2024 | New Jersey Law Journal

LegalZoom Sued for Alleged Unauthorized Practice of Law

LegalZoom allegedly engages in the unauthorized practice of law because it does not fit the statutory definition of a professional service corporation and because its owners include nonlawyers, according to the complaint.
5 minute read
June 04, 2024 | National Law Journal

Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement, False Advertising

"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
4 minute read
June 04, 2024 | Law.com

Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement, False Advertising Across U.S.

"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
4 minute read
June 03, 2024 | The Legal Intelligencer

Lawyers Forge On With Ozempic Litigation Amid MDL Reassignment Uncertainty

"When a client reads that their judge has passed, it is a scary, scary thing," said Jonathan Orent, a member at Motley Rice.
4 minute read
May 21, 2024 | National Law Journal

DC Circuit Sides With Manufacturers in '340B' Drug Discount Dispute

"[W]e cannot plausibly interpret statutory silence to subject manufacturers to whatever delivery conditions any covered entity might find most convenient," Judge Gregory Katsas wrote for the appeals court.
4 minute read
May 09, 2024 | The Legal Intelligencer

Judge Expands Ozempic Plaintiffs' Leadership Team, Names 4 Co-Lead Counsel

In a joint statement, the newly appointed leads said they "are honored to have been appointed by Judge Pratter to lead one of the most significant and consequential pharmaceutical injury cases of our time against the manufacturers of diabetes and weight loss drugs such as Ozempic and Wegovy."
3 minute read
April 25, 2024 | New Jersey Law Journal

As Eli Lilly's Insulin Pricing Settlement Unravels, Lawyers Vow to Push Ahead

Lawyers touting a $500 million settlement over insulin pricing are back at the drawing board after a judge refused to certify their class.
5 minute read
April 24, 2024 | The Legal Intelligencer

Ozempic Plaintiffs Get Leadership Team, but Not Quite the One They Asked For

Walsh said that, during an extensive hearing on leadership structure last week, Pratter "had some concerns about the size of the committee that we put in the application."
4 minute read

Resources

  • 2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates

    Brought to you by LexisNexis® CounselLink®

    Download Now

  • AI in Private Equity: A Guide for Gaining an Early Advantage

    Brought to you by Ontra

    Download Now

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now